Testosterone Therapy for Men: What’s Hype and What’s Evidence?
TRT is everywhere. Here’s what the data says about who benefits, what the risks are, and why it’s rarely just about testosterone alone.
September 3, 2026
Testosterone Therapy for Men: What’s Hype and What’s Evidence?
TRT is everywhere. Here’s what the data says about who benefits, what the risks are, and why it’s rarely just about testosterone alone.
Category:
Health
Ask ten men what they know about TRT and you’ll get ten answers. Ask how many of them have actually read the research, and the room gets quiet fast.
Testosterone replacement therapy has become one of the most talked-about — and misunderstood — topics in men’s health.
Some of the info that circulates is solid. But a lot of it is bro-science disguised as biology, or marketing copy from a clinic trying to sell an “optimization” package.
The truth is somewhere between the hype and the skepticism, which is what we’re here to share with you.
What low testosterone looks like
Testosterone naturally declines by about 1% per year starting around age 30. For some men, that decline is usually slow and unremarkable.
But for some, it drops enough to cause symptoms like:
- Low energy and motivation
- Low libido or erectile dysfunction
- Loss of muscle mass or strength
- Mood changes, irritability, or brain fog
- In some cases, anemia or reduced bone density
The prevalence is higher than you’d think. Between 12% and 39% of men in their 50s through 80s have testosterone deficiency, and about 35% of men over 45 fall into that range.
Rates climb even higher for men with obesity or type 2 diabetes. Diagnosis is more than just a number, though.
The American Urological Association sets the threshold at under 300 ng/mL, and requires two separate early-morning fasting blood tests plus real symptoms before that number means anything clinically.
A single low reading on a random afternoon lab doesn’t diagnose hypogonadism. Neither does a low number without symptoms attached.
That distinction is exactly where a lot of the hype gets ahead of the evidence. Treating a number instead of treating a person creates problems down the line.
What the evidence shows
For years, TRT carried a cloud of uncertainty around cardiovascular risk. Older observational studies raised alarms, the FDA required a warning label, and major guidelines reflected that caution for over a decade.
Then came the TRAVERSE trial.
This is the largest randomized, placebo-controlled trial ever run on testosterone therapy: 5,426 men, ages 45 to 80, all with existing cardiovascular disease or high cardiovascular risk. Half of them received testosterone gel, half received placebo, for an average of 27 months.
The result: testosterone therapy was non-inferior to placebo for major cardiovascular events. No increased heart attack or stroke risk. No increased prostate cancer risk either — a separate long-standing worry that also didn’t hold up.
The trial did surface two findings worth talking about with a prescriber:
- Slightly more cases of atrial fibrillation in the testosterone group
- Slightly more fractures in the testosterone group
Both matter, especially for men with existing heart rhythm issues or bone health concerns.
On the flip side, the same data showed a notable reduction in progression to type 2 diabetes among men with prediabetes at baseline.
So the honest read is this: for men with a genuine diagnosis, properly monitored, TRT looks considerably safer than the headlines suggested.
That’s not a case for casual use in men without a real deficiency. But, it does show that treating true hypogonadism, in the right patient, under clinical supervision, holds up to scrutiny.
It’s rarely just testosterone
Most of the online conversation skips this part.
A well-run TRT protocol is almost never just an injection of testosterone and nothing else. Three other compounds routinely show up alongside it, each solving a different problem testosterone alone creates.
hCG (human chorionic gonadotropin)
When testosterone is delivered externally, the body’s own production shuts down. The brain senses plenty circulating and stops signaling the testes to make more. Over months, that can mean testicular shrinkage and a steep drop in fertility.
hCG mimics the body’s natural signal (LH) directly at the testes, keeping them active and producing testosterone on their own, even while a man is on external testosterone. It’s the most common tool for men on TRT who want to preserve fertility, or just avoid testicular atrophy.
Anastrozole
Testosterone doesn’t stay as testosterone forever. Some of it naturally converts to estrogen through an enzyme called aromatase.
A little estrogen is necessary and healthy. Too much (which can happen when testosterone doses run high) shows ups as water retention, moodiness, or breast tissue changes.
Anastrozole blocks that conversion, keeping estrogen in a healthy range alongside testosterone. It’s a fine-tuning tool, not a required addition for every man.
Overusing it can push estrogen too low, which brings its own problems: joint pain, low libido, mood changes, and disrupted lipid levels.
Enclomiphene
This one works differently and is increasingly popular for a specific reason: it raises testosterone without external testosterone at all.
Enclomiphene blocks the estrogen-driven feedback signal that normally tells the brain, “We have enough testosterone, slow down production.” With that brake removed, the brain ramps up its own signal to the testes, and natural testosterone production rises. Because it works upstream rather than replacing testosterone directly, sperm production and fertility are preserved, unlike standard TRT, which suppresses both.
A 2013 trial found men on enclomiphene maintained or increased sperm concentration over three months, while men on standard testosterone gel saw sperm counts drop sharply.
Enclomiphene isn’t FDA-approved as a finished drug, so it’s available only through compounding pharmacies with a prescription. But the clinical data behind it is solid for the specific population it serves, which is men who want higher testosterone without giving up fertility.
None of these three is right for every man. Which one (if any) makes sense depends entirely on labs, symptoms, and goals. That’s exactly why this is not a protocol you build from a podcast you listened to.
Why this is important to your practice
Clients hear “TRT” and think it means one thing: an injection, a vial, a straightforward fix.
The reality is a bit more sophisticated. And that sophistication is where real, credentialed care distinguishes itself from a sketchy online clinic shipping vials with no follow-up.
A client asking about testosterone deserves more than a yes or no. They deserve lab work and a conversation about what they’re optimizing for — symptoms, fertility, or both.
That’s a conversation worth having. And it’s the kind of nuance that builds trust long after the first prescription.
FAQs
Is testosterone therapy safe?
For men with a confirmed diagnosis under medical supervision, the evidence supports a favorable safety profile, including no increased cardiovascular or prostate cancer risk.
Slightly elevated rates of atrial fibrillation and fractures were observed and are worth talking about with a prescriber. Safety data for men without a true diagnosis using testosterone for “optimization” is quite sparse.
Does testosterone therapy cause infertility?
Standard testosterone therapy does suppress natural sperm production, often significantly. That’s because the body senses enough testosterone and stops signaling the testes to produce it
This is reversible in most men after stopping treatment, but it can take months.
Additions like hCG or alternatives like enclomiphene are used to prevent or minimize this effect in men who want to preserve fertility.
What’s the difference between hCG and enclomiphene?
Both aim to protect natural testosterone production and fertility, but they work at different points in the system. hCG acts directly on the testes, mimicking the body’s natural signal. Enclomiphene acts at the brain, removing the signal that tells the body to slow down production.
The right choice depends on the individual goals and clinical context.
Do all men on TRT need anastrozole?
No. Anastrozole is used selectively for men whose estrogen levels run high enough to cause symptoms.
Used unnecessarily, it can push estrogen too low, which creates its own set of problems.
It’s a tool for specific cases, not a default addition for everyone.
Where this leaves you
TRT isn’t a myth, but it’s also not a miracle.
It’s a legitimate, well-studied treatment for a real, common, and historically undiagnosed condition. It has genuine evidence behind it, genuine risks worth monitoring, and a level of clinical nuance that rarely makes it into the online chats.
For wellness businesses fielding these questions, that nuance is the opportunity.
Altro Health gives wellness businesses the clinical infrastructure to offer real testosterone therapy with:
- Proper lab testing
- Licensed prescribers
- Full range of protocols, from testosterone itself to hCG, anastrozole, and enclomiphene
All this is done under your brand.
The men asking about TRT deserve more than a vial and a guess. Be the practice that gives them the real thing with real results.
Sources
Hypogonadism in Men | Endocrine Society
Evaluation and Management of Testosterone Deficiency (2024) | American Urological Association
Cardiovascular Safety of Testosterone-Replacement Therapy | The New England Journal of Medicine
Clomiphene Citrate for the Treatment of Hypogonadism | ScienceDirect
Related blogs
wellness designed for growth
expand your business and give more to your clients.
